Unidad de Investigación en Enfermedades Metabólicas (UIEM)

Información para profesionales de la salud (UIEM)

A continuación se presentan algunas de las publicaciones realizadas por los investigadores de la Unidad de Investigación de Enfermedades Metabólicas (UIEM). Consulta su contenido dando click en el nombre del artículo:

Publicaciones

• A Higher Fructose Intake Is Associated with Greater Albuminuria in Subjects with Type 2 Diabetes Mellitus
• A Loss of Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes.
• Associations of autozygosity with a broad range of human phenotypes
• A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.
• Arterioscler Thromb Vasc Biol-2016-Rodríguez-ATVBAHA.116.307182
• Assessment of two different diagnostic guidelines criteria (National Cholesterol Education Adult Treatment Panel III [ATP III] and Internacional Diabetes Federation)
• Attributable burden and expenditure of cardiovascular diseases and associated risk factors in mexico and other selected mega countries
• Bloodstream infection caused by S aureus in patients with cancer a 10 year longitudinal single center study
• Both Twice Daily in Elderly Patients with Type 2 Diabetes Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials
• Cholesterol efflux capacity of large small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes
• Collaborative research and actions on both sides of the US-Mexico border to counteract type 2 diabetes in people of Mexican origin
• Comorbid conditions in individuals assessed by SPECT Study of a reference cardiology center in Mexico City
• Comparative efficacy safety and cardiovascular outcomes with once weekly subcutaneous semaglutide in the treatment of type 2 diabetes
• Contribution of known genetic risk variants to dyslipidemias and type 2 diabetes in Mexico A population based nationwide study
• Contribution of known genetic risk variants to dyslipidemias and type 2 diabetes in Mexico A population based nationwide study
• Cost Effectiveness of Insulin Degludec vs Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting Diabetes Therapy
• Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
• Determinación del índice glucémico y carga glucémica de las barras de cereales industrializadas
• Determinants of VLDL composition and apo B containing particles in familial combined hyperlipidemia.
• Development and validation of a predictive model for incident type 2 diabetes in middle aged Mexican adults the metabolic syndrome cohort.
• Diagnostic challenge of glucagonoma case report and literature review.
• Diastolic dyssynchrony assessment by gated myocardial perfusion SPECT in subjects who underwent cardiac resynchronization therapy
• Diurnal Variation in PDK4 Expression Is Associated With Plasma Free Fatty Acid Availability in People
• Dyslipidemia in Mexico, a Call for Action
• Empowerment of patients with type 2 diabetes current perspectives. Diabetes Metab Syndr Obes.
• Environmental and intrinsic factors shaping gut microbiota composition and diversity and its relation to metabolic health in children and early adolescents A po
• Epidemiology of Diabetes 1 Mellitus in Mexico
• Evidence of how rs7575840 influences apolipoprotein B containing lipid particles.
• Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls
• Factors Associated with Insulin Nonadherence in Type 1 Diabetes Mellitus Patients in Mexico.
• Factors associated with postprandial lipemia and apolipoprotein A V levels in individuals with familial combined hyperlipidemia.
• Factors influencing achievement of low density lipoprotein cholesterol goals in Mexico the international cholesterol management practice study
• Familial combined hyperlipidemia current knowledge perspectives and controversies.
• Favorable Effect of Bromocriptine and Pentoxifylline in Mild Graves Disease Orbitopathy A Randomized Open Clinical Trial
• Fibroblast Growth Factor 21 and Browning of White Adipose Tissue
• Galanin preproprotein is associated with elevated plasma triglycerides.
• Genome wide association study of colorectal cancer in Hispanics.
• Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci.
• Higher Fructose Intake Is Associated with Greater Albuminuria in Subjects with Type 2 Diabetes Mellitus.
• Identification of a threshold to discriminate fasting hypertriglyceridemia with postprandial values.
• II. The research ethics involving vulnerable groups
• Índices para la evaluación de la resistencia a la insulina en individuos mexicanos sin diabetes
• Insulin Adherence in Type 2 Diabetes in Mexico Behaviors and Barriers. Journal of Diabetes Research
• Macroprolactinemia as a cause of hyperprolactinemia. Series of cases
• Meningeal syndrome in a patient treated with a combination of immune checkpoint inhibitors for a metastatic melanoma
• Mental health in patients with obesity who attend bariatric surgery protocol La salud mental en el paciente con obesidad en protocolo para cirugía bariátrica
• Metabolic Score for Visceral Fat METS VF , a novel estimator of intra-abdominal fat content and cardio metabolic health
• Metabolomics in diabetes, a review.
• METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes
• Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas.
• Modulation of energy balance by fibroblast growth factor 21
• Molecular Characterization of the Lipid Genome Wide Association Study Signal on Chromosome 18q11.2 Implicates HNF4A-Mediated Regulation of the TMEM241 Gene.
• Multiethnic polygenic risk scores improve risk prediction in diverse populations.
• Multinational Consensus Insulin Initiation with Insulin Degludec Aspart.
• Noncholestatic acute hepatocellular injury following candesartan administration
• Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics.
• Overview of the current status of familial hypercholesterolaemia care in over 60 countries The EAS Familial Hypercholesterolaemia Studies Collaboration FHSC.
• Pathophysiological mechanisms linking type 2 diabetes and dementia Review of evidence from clinical, translational and epidemiological research.
• Percutaneous muscle biopsy induced tissue injury causes local endoplasmic reticulum stress.
• Performance of LDL C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemia. Atherosclerosis.
• Posición de la Sociedad Mexicana de Nutrición y Endocrinología sobre los edulcorantes no calóricos
• Prediction of incident hypertension and arterial stiffness using the non insulin based metabolic score for insulin resistance METS IR index
• Prevalence of non nutritive sweeteners consumption in a population of patients with diabetes in Mexico
• Process evaluation in the field global learnings from seven implementation research hypertension projects in low-and middle income countries.
• Proliferative Properties of 17B aminoestrogens in MCF 7 Human Breast Cancer Cells.
• Prevention of diabetes in Mexico Summary of evidence on preventive interventions presented at the 2014 Nestle Nutrition Conference
• Quality of life is significantly impaired in both secretory and non functioning pituitary adenomas.
• R230C but not 565CT variant of the ABCA1 gene is associated with type 2 diabetes in Mexicans through an effect on lowering HDLcholesterol levels.
• Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes.
• Recent advances in managing understanding the metabolic syndrome
• Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia
• Residual vascular risk in diabetes Will the SPPARM alpha concept hold the key
• Review of the scientific evidence and technical opinion on noncaloric sweetener consumption in gastrointestinal diseases
• Setting the Lipid Component of the Diet a Work in Process
• Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.
• Sitagliptin phosphate treatment in patients with reactive hypoglycemia secondary to dysinsulinism. Controlled, randomized, double blind study
• Successful Multimodal Treatment of an IGF2 Producing Solitary Fibrous Tumor with Acromegaloid Changes and Hypoglycemia
• Sucralose decreases insulin sensitivity in healthy subjects a randomized controlled trial.
• TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia.
• The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetes
• The development of the Mexican Familial Hypercholesterolemia FH National Registry Atherosclerosis
• The hyperlipidemia diagnosis based on phenotype El diagnóstico de hiperlipidemia basado en el fenotipo.
• The management of incidental fatty liver found on imaging what
• The development of the Mexican Familial Hypercholesterolemia FH National Registry Atherosclerosis
• The hyperlipidemia diagnosis based on phenotype El diagnóstico de hiperlipidemia basado en el fenotipo
• the management of incidental fatty liver found on imaging what
• The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans
• The panorama of familial hypercholesterolemia in Latin America A systematic review
• The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large size adipocytes.
• Transancestral mapping and genetic load in systemic lupus erythematosus
• Type 1 diabetes incidence in children and adolescents in Mexico Data from a nation-wide institutional register during 2000 2018
• Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms
• Visceral obesity, skeletal muscle mass and resistin in metabolic syndrome development

Herramientas para la investigación

• Estimadores de la acción de la insulina
• Registro Mexicano de Hipercolesterolemia Familiar